Skip to main content

Advertisement

Table 1 Clinical and Demographic characteristics of subjects involved in the study with respect to number of individuals, age of diagnosis, duration of disease, genotype and antibody number.

From: Lack of correlation between the levels of soluble cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and the CT-60 genotypes

Variable AbN AbP T1D
Total number 117 19 82
Age (years) 15.1 14.5 15.8
   75%ile 22.0 28.5 20.1
   90%ile 37.0 37.0 36.0
Age range (0.8–48.6) (0.6–44.0) (0.9–43.7)
Age of Diagnosis (years)    8.8 (0.8–41.2)
Duration of T1D (years)    6.2 (0–41.0)
Age: n (percent)    
<20 years 86 (73.51) 14 (73.68) 60 (73.17)
>20 years 31 (26.49) 5 (26.32) 22 (26.83)
Sex: n (percent)    
Male 53 (45.30) 9 (47.37) 50 (60.97)
Female 64 (54.70) 10 (52.63) 32 (39.03)
Genotype: n (percent)*    
0201/0201 8 (6.84) 0 (0.00) 13 (15.85)
0302/0302 12 (10.26) 4 (21.05) 6 (7.32)
0201/0302 31 (26.50) 5 (26.32) 38 (46.34)
0201/x 21 (17.95) 3 (15.79) 10 (12.20)
0302/x 23 (19.66) 4 (21.05) 11 (13.41)
x/x 18 (15.38) 2 (10.53) 3 (3.66)
  1. Age, age of diagnosis and duration of disease is presented as means (range).
  2. *Genotyping information was not available on one AbP, one T1D and 4 AbN individual(s).
  3. Sex and genotype are presented as number of individuals of individuals (n). Values presented in parenthesis are percentage of total.